Plerixafor Overcomes the Adverse Effect of Diabetes on Hematopoietic Progenitor Cell Mobilization

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2012.11.198
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Hematopoietic Stem Cell Mobilization With Plerixafor in Sickle Cell Disease

Haematologica
Hematology
2018English

Efficacy of Late Hematopoietic Stem Cell Mobilization 35-40 Hours After Administration of Plerixafor

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Cooperation of Β2- And Β3-Adrenergic Receptors in Hematopoietic Progenitor Cell Mobilization

Annals of the New York Academy of Sciences
GeneticsMolecular BiologyBiochemistryNeuroscienceHistoryPhilosophy of Science
2010English

Allogeneic Hematopoietic Stem Cell Transplant Overcomes the Adverse Survival Effect of Very High Risk and Unfavorable Karyotype in Myelofibrosis

American Journal of Hematology
Hematology
2018English

Plerixafor for Stem Cell Mobilization in Allogeneic Stem Cell Donors

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Rapid Hematopoietic Progenitor Mobilization by Sulfated Colominic Acid

Biochemical and Biophysical Research Communications
BiochemistryCell BiologyMolecular BiologyBiophysics
2007English

Hematopoietic Stem Cell Mobilization

Haematologica
Hematology
2008English

Effect of Peripheral Blood Progenitor Cell Dose on Hematopoietic Recovery: Identification of Minimal Progenitor Cell Requirements for Rapid Engraftment

Bone Marrow Transplantation
TransplantationHematology
2004English

Progenitor Cell Mobilization by Gamma-Tocotrienol

Health Physics
Nuclear MedicineRadiologyMutagenesisEpidemiologyHealthImagingToxicology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy